1. Home
  2. INDP vs QH Comparison

INDP vs QH Comparison

Compare INDP & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • QH
  • Stock Information
  • Founded
  • INDP 2000
  • QH 2012
  • Country
  • INDP United States
  • QH China
  • Employees
  • INDP N/A
  • QH N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • QH Business Services
  • Sector
  • INDP Health Care
  • QH Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • QH Nasdaq
  • Market Cap
  • INDP 6.0M
  • QH 5.9M
  • IPO Year
  • INDP N/A
  • QH 2020
  • Fundamental
  • Price
  • INDP $2.41
  • QH $6.70
  • Analyst Decision
  • INDP Strong Buy
  • QH
  • Analyst Count
  • INDP 2
  • QH 0
  • Target Price
  • INDP $238.00
  • QH N/A
  • AVG Volume (30 Days)
  • INDP 199.1K
  • QH 95.1K
  • Earning Date
  • INDP 11-11-2025
  • QH 08-28-2025
  • Dividend Yield
  • INDP N/A
  • QH N/A
  • EPS Growth
  • INDP N/A
  • QH N/A
  • EPS
  • INDP N/A
  • QH 0.80
  • Revenue
  • INDP N/A
  • QH $417,431,053.00
  • Revenue This Year
  • INDP N/A
  • QH N/A
  • Revenue Next Year
  • INDP N/A
  • QH N/A
  • P/E Ratio
  • INDP N/A
  • QH $8.29
  • Revenue Growth
  • INDP N/A
  • QH N/A
  • 52 Week Low
  • INDP $2.22
  • QH $3.93
  • 52 Week High
  • INDP $58.24
  • QH $169.07
  • Technical
  • Relative Strength Index (RSI)
  • INDP 22.05
  • QH 26.97
  • Support Level
  • INDP $2.22
  • QH $6.01
  • Resistance Level
  • INDP $2.86
  • QH $7.07
  • Average True Range (ATR)
  • INDP 0.67
  • QH 0.60
  • MACD
  • INDP -0.18
  • QH 2.93
  • Stochastic Oscillator
  • INDP 3.86
  • QH 88.09

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.

Share on Social Networks: